30|day mortality after systemic anticancer treatment for breast and ...

Mortality within 30 days following systemic anti-cancer therapy (SACT)

Monthly morbidity and mortality audits conducted to recommendations in the NCEPOD commenced at the Christie NHS Foundation Trust since 2009. We sought to ...

Palliative Care Interventions and End-of-Life Care for Patients with ...

However, PC intervention > 30 days is associated with less chemotherapy in the last month before death. Further studies are needed to better ...

Thirty-Day Mortality After Curative and Palliative Anti-Cancer ...

Purpose: Despite advancements in cancer therapeutics, mortality and morbidity due to anti- cancer treatments still occur but are not frequently reported.

Direct and indirect effects of COVID-19 on short-term mortality of ...

Survival within the year of diagnosis was 97.6% in 2020 and 98.3% in 2019; 30-day mortality was 1.13% in 2020 (1.07 in uninfected patients), and ...

Breast Cancer Treatment (PDQ®) - NCI

The optimal sequence of adjuvant chemotherapy and radiation therapy after breast-conserving surgery has been studied. Based on the following ...

Consent forms for SACT (Systemic Anti-Cancer Therapy)

Breast, Mar-20, Mar-23. Children & Young Person ALL, Aug-23, Aug-26 ... Read a world first population based study of 30-day mortality following SACT in England.

Evaluation of COVID-19 Mortality and Adverse Outcomes in US ...

Compared with patients without cancer, patients with recent cancer treatment had a significant increase in the risk of death (OR, 1.74; 95% CI, ...

Systemic Anti-Cancer Therapy (SACT) Dataset

Wallington M, Saxon EB, Bomb M, Smittenaar R, Wickenden M, McPhail S et al. 30-day mortality after systemic anticancer treatment for breast and ...

Patterns of chemotherapy use and outcomes in advanced non-small ...

We used the Systemic Anti-Cancer Treatment (SACT) dataset to describe changes in treatment plan and estimated 30 and 90-day mortality rates and ...

Defining the expected 30-day mortality for patients undergoing ...

The overall 30-day mortality rate after palliative radiotherapy is found to be 16%. •. Certain subgroups have higher/lower rate of palliative ...

Measuring variation in the quality of systemic anti-cancer therapy ...

Adjusted toxicity rates varied from 11% to 49% (adjuvant) and from 25% to 67% (metastatic). •. Twelve hospitals had toxicity rates >2SD ...

Morbidity and mortality among patients with breast cancer receiving ...

The present retrospective study reviews the 30-day morbidity and mortality rates of patients with breast cancer receiving anticancer systemic treatment

Systemic anti-cancer therapy (SACT) data set: collecting and using ...

Wallington M, Saxon EB, Bomb M, et al. 2016. 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, ...

Mortality within 30 days after last dose of intravenous systemic anti ...

Mortality within 30 days of systemic anti-cancer therapy may be a useful indicator of the preventable harm to patients from systemic anti-cancer therapy ...

Mortality within 30 days of systemic anticancer therapy at a tertiary ...

Mortality within 30 days of systemic anticancer therapy at a tertiary cancer centre: assessing the safety and quality of clinical care. Full ...

Machine Learning Approach to Assess Short-term Mortality Risk ...

To illustrate model discrimination, patients were ranked initiating palliative chemotherapy by model-predicted mortality risk, and observed ...

Systemic Anticancer Treatment Near the End of Life - OUCI

Facilitating early integration of palliative care into breast cancer therapy. ... 30-day mortality after systemic anticancer treatment for breast and lung ...

Chemotherapy is powerful stuff but data is too - UKHSA blog

In our data among 15,626 breast cancer patients receiving curative treatment there were 41 deaths within 30 days and among the 1,961 non ...

The Breast

30-day mortality after systemic anticancer treatment for breast and lung cancer in. England: a population-based, observational study. Lancet ...

Longest follow-up of patients with early breast cancer shows ...

However, after the first ten years, the annual risk of a recurrence was similar in both groups, as was overall survival: 30 years after their ...